• The Value of Prediction, and Cost of Success, in Drug Hunting

    Mar 26 | Bio-IT World | Across the pharmaceutical industry, generative artificial intelligence is now running an estimated 10 to 20 million predictions a day in a quest to accelerate drug discovery by exploring new molecules and chemical reactions at an unprecedented pace. Access to hardware determines AI capabilities, but the tech-driven process of making medicines is still “done by people for people,” with a human in the loop calling the shots and running the machinery. More

  • Follow the Money: Brain-Computer Retinal Implant, Expansion of Alzheimer’s Platform, Migraine Therapies

    Mar 25 | Bio-IT World | Science Corporation accelerates the commercialization of their brain-computer interface retinal implant, PRIMA; Cognito Therapeutics prepares for commercial launch of their Spectris platform; Slate Medicines receives in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody targeting PACAP for the prevention of migraine and other headache disorders; and more. More

  • Verily, Samsung Collaborate, Improving AI Trustworthiness, FDA Approval for PathAI

    Mar 24 | Bio-IT World | Verily Life Sciences and Samsung Electronics America announce a collaboration; Research Solutions launches Scite MCP; PathAI announces Breakthrough Device Designation to PathAssist Derm; and more. More

  • PerturbAI Launches with CRISPR Atlas

    Mar 20 | Bio-IT World | PerturbAI unveiled the world’s largest in vivo CRISPR atlas this week as it emerged from stealth. The 8 million-cell, brain-wide dataset represents the largest known causal genomics resource generated directly in living tissue. More

  • piRNAs Emerge as a New Frontier in Longevity

    Mar 19 | Bio-IT World | Paul Stamets has spent more than four decades in the forests of the Pacific Northwest, carefully prying tissue samples from the undersides of some of the world’s rarest mushrooms. On the stage of February’s Integrative Health Symposium, that lifetime of fieldwork converged with randomized clinical trials and Department of Defense contracts—a collision of ancient ethnobotany and 21st-century immunology that left the audience energized. More

  • Open Source ‘Floats All Boats’ in AI-Driven Drug Discovery

    Mar 17 | Bio-IT World | More than two dozen “grand challenges” remain in small-molecule drug discovery, spanning everything from target selection to developing a medicine that can be safely used in the clinic. No single company can solve all these problems alone, which underscores the importance of computational tools, many of which are built on open-source software. More

  • Ancient Mushroom, Modern Medicine: Paul Stamets Says Agarikon Mycelium May Be Key to Fighting Viral Pandemics

    Mar 12 | Bio-IT World | Paul Stamets has spent more than four decades in the forests of the Pacific Northwest, carefully prying tissue samples from the undersides of some of the world’s rarest mushrooms. On the stage of February’s Integrative Health Symposium, that lifetime of fieldwork converged with randomized clinical trials and Department of Defense contracts—a collision of ancient ethnobotany and 21st-century immunology that left the audience energized. More

  • Russia to Expand National Genetics Database to Ensure Treatment for Various Ethnic Groups

    Mar 11 | Bio-IT World | Russia is significantly expanding the existing national database of genetic variant frequencies of the domestic population in a move to improve treatment of some socially important diseases and reduce the mortality rate from them. More

  • How HPC Systems Are Making Things Easier

    Mar 10 | Bio-IT World | In the newest episode of Trends from the Trenches, guest host Jessica StLouis, senior scientific consultant at BioTeam, speaks with Jarett DeAngelis, director of scientific computing, and Shane Corder, senior HPC engineer, both at the Moffitt Cancer Center. Their conversation centers on how Moffitt is redesigning HPC infrastructure to reduce friction in research collaboration, streamline data sharing, and expand access to advanced computational resources. More

  • Infant Microbiome Atlas Makes Case for Region-Specific Probiotics

    Mar 05 | Bio-IT World | In the newest episode of Trends from the Trenches, guest host Jessica StLouis, senior scientific consultant at BioTeam, speaks with Jarett DeAngelis, director of scientific computing, and Shane Corder, senior HPC engineer, both at the Moffitt Cancer Center. Their conversation centers on how Moffitt is redesigning HPC infrastructure to reduce friction in research collaboration, streamline data sharing, and expand access to advanced computational resources. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!